13F Data
Security · CUSIP 55414P702

MABVAX THERAPEUTICS

EQUITIES · institutional ownership from 13F filings
13F holders
2
Shares held
35.3K
Value held
$15.0K
New / sold out
1 / 14
Added / reduced
0 / 0
net -1.3M shares

13F holders by quarter

Q1 2018: 11Q2 2018: 15Q3 2018: 2Q4 2018: 2Q1 2019: 1Q2 2019: 2Q3 2019: 0Q3 2021: 1Q4 2021: 1Q1 2022: 0Q2 2022: 1Q3 2022: 1Q4 2022: 0
Q1 2018Q4 2022

Net shares bought by existing holders

Q1 2018: 1.1MQ2 2018: 192.3KQ3 2018: -1.3MQ4 2018: 10.1KQ1 2019: -2.5KQ2 2019: 582.9KQ3 2019: -616.8KQ3 2021: 23Q4 2021: 0Q1 2022: -23Q2 2022: 23Q3 2022: 0Q4 2022: -23
Q1 2018Q4 2022

Top holders · Q3 2018

ManagerSharesValue% of portfolio
PANAGORA ASSET MANAGEMENT INC26,382$11.0K0.00%
Biomark Capital Management Co. LLC8,903$4.0K0.04%

Biggest buyers

ManagerChangeShares changeChange %
PANAGORA ASSET MANAGEMENT INCNew+26,382–

Biggest sellers

ManagerChangeShares changeChange %
Cambridge Investment Research Advisors, Inc.Sold out-1,030,310-100.0%
VANGUARD GROUP INCSold out-126,592-100.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out-75,904-100.0%
COMMONWEALTH EQUITY SERVICES, LLCSold out-27,865-100.0%
CITADEL ADVISORS LLCSold out-27,385-100.0%
Virtu Financial LLCSold out-12,783-100.0%
UBS Group AGSold out-11,889-100.0%
BANK OF AMERICA CORP /DE/Sold out-6,664-100.0%
ROYAL BANK OF CANADASold out-2,999-100.0%
CLS Investments, LLCSold out-333-100.0%
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.